Results 121 to 130 of about 400,270 (268)

A real-time, gamified approach for optimizing intra-hospital transport of time-critical biospecimens. [PDF]

open access: yesFront Digit Health
Bundschuh A   +6 more
europepmc   +1 more source

Acute toxic leucoencephalopathy following protonitazene ingestion

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Background Distribution of illicit counterfeit alprazolam containing the highly potent synthetic opioid‐receptor agonist protonitazene recently resulted in a number of severe overdoses in Ireland. We report three cases that presented to our hospital, within 6 weeks of one another, following ingestion of illicitly‐sourced alprazolam.
Ruadhan O'Laoi   +5 more
wiley   +1 more source

Glucagon‐like peptide‐1 receptor agonists in schizophrenia spectrum disorders: A systematic review and meta‐analysis of efficacy, safety and mental health outcomes

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims The purpose of this study is to evaluate efficacy, safety and mental‐health outcomes of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in adults with overweight or obesity and antipsychotic‐treated schizophrenia‐spectrum disorders. Methods PubMed/MEDLINE, Embase, PsycINFO, CENTRAL, Virtual Health Library (VHL) (Biblioteca Virtual em Saúde, BVS),
Débora Regina de Aguiar   +10 more
wiley   +1 more source

Aberrant CD4 expression in plasmablastic transformation of multiple myeloma

open access: yeseJHaem
Kohei Shiroshita   +5 more
doaj   +1 more source

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

open access: yesBiotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga   +2 more
wiley   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

open access: yesBMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo   +9 more
wiley   +1 more source

Workplace violence against hospital personnel in Tunisia: prevalence, associated psychological and behavioral outcomes, and legal actions. [PDF]

open access: yesFront Public Health
Mallek Z   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy